Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 1972;39:873-879
© 1972 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HORGER, E. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HORGER, E. O., III

Sickle Cell and Sickle Cell-Hemoglobin C Disease During Pregnancy

EDGAR O. HORGER, III, MD, FACOG

From the Department of Obstetrics and Gynecology, Medical University of South Carolina, 80 Barre St, Charleston, SC 29401.

Abstract

Forty-five pregnancies in patients with homozygous hemoglobin S disease and 9 pregnancies in patients with sickle cell-hemoglobin C disease are reported. An increased incidence of toxemic and infectious complications was noted. Severe anemia was seen quite often, and many patients developed some degree of cardiac decompensation. Bone pain crises were frequent. Many patients went into labor prematurely, and infants small for gestational age often were delivered. Perinatal mortality rates were 24% in homozygous hemoglobin S disease and 62% in sickle cell-hemoglobin C disease. Four maternal deaths attributable to these hemoglobinopathies are reported. Increased use of surgical sterilization and therapeutic abortion in these patients seems to be justified.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1972 by the American College of Obstetricians and Gynecologists.